Future Treatment of ILD

In your rheumatic patients with ILD, who usually treats the ILD?

What determines which patients will be treated for ILD?

Which class of drugs do you most rely on in treating ILD:

Patients with ILD – what Immunosuppressants do you rely on?

With Autoimmune disease and ILD - what is the value of antifibrotics or IL-6 inhibitors?

What is the value of immunosuppressants (eg MMF) in ILD?

I treat autoimmune related ILD, because these patients have:

Which Guidelines for ILD in systemic autoimmune rheumatic disease (SARD) are you familiar with:

Which drug is proven to be “anti-fibrotic”?

Which is your practice setting?

Please select:

×